Acubalance Wellness Centre, a pioneer in integrative fertility care and an early adopter of low-level laser therapy (LLLT) for fertility and IVF, welcomes new evidence supporting its innovative approach to improving frozen embryo transfer (FET) outcomes. LLLT, also known as photobiomodulation, has been a cornerstone of Acubalance’s fertility treatments, and a recent clinical study confirms its effectiveness for those facing recurrent implantation failure (RIF).
HealthTech Insights: Roswell Park Team Identifies Factors That Boost Effectiveness of Immunotherapy in Recurrent Ovarian Cancer
The study published in June 2024, titled Low-Level Laser Therapy for Improvement of In Vitro Fertilization Outcomes in Patients with Recurrent Implantation Failure: A Randomized Clinical Trial, investigated the impact of LLLT on women aged 24 to 39 who had experienced at least three failed embryo transfers with high-quality embryos. The findings showed that LLLT improved biochemical pregnancy rates (46.7% vs. 33.3%) and clinical pregnancy rates (33.3% vs. 20%) compared to a control group, confirming its ability to enhance uterine blood flow and endometrial receptivity.
HealthTech Insights: Roswell Park Team Discovers New Treatment Target for Neuroendocrine Prostate Cancer
“This study validates what we’ve observed in practice: low-level laser therapy (LLLT) significantly improves frozen embryo transfer outcomes,”
says Dr. Lorne Brown
HealthTech Insights: Global Clinical Trials Connect Conference 2025: Collaboration, Innovation and Enhancing Quality in Clinical Trials
Acubalance has been at the forefront of incorporating LLLT for fertility, offering this non-invasive, evidence-based therapy as part of a comprehensive plan that also includes acupuncture and naturopathic medicine. LLLT works by using low-intensity red and infrared light to stimulate cellular activity, promote tissue repair, and create a healthier uterine environment for successful embryo implantation.
HealthTech Insights: Clinical Trial Supply and Logistics Market Size Expected to Reach USD 8.58 Bn by 2034
“This study supports what we’ve seen in practice for years: LLLT can significantly improve FET outcomes,” says Dr. Lorne Brown, founder of Acubalance. “We are proud to continue leading in integrative fertility care and providing our patients with proven solutions.”
To participate in our interviews, please write to our HealthTech Media Room at news@intentamplify.com
Source – prweb
